Log in to save to my catalogue

Early Outpatient Treatment for Covid-19 with Convalescent Plasma

Early Outpatient Treatment for Covid-19 with Convalescent Plasma

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9006786

Publication information

Publisher

United States: Massachusetts Medical Society

More information

Scope and Contents

Contents

In this multicenter, double-blind trial of convalescent plasma for early, symptomatic SARS-CoV-2 infection, 1225 patients were randomly assigned to receive convalescent plasma or control plasma within 9 days after the onset of symptoms. Significantly fewer recipients of convalescent plasma had progression of Covid-19–associated illness leading to h...

Alternative Titles

Full title

Early Outpatient Treatment for Covid-19 with Convalescent Plasma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9006786

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9006786

Other Identifiers

ISSN

0028-4793

E-ISSN

1533-4406

DOI

10.1056/NEJMoa2119657

How to access this item